CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs,...
Phase 1
La Jolla, California, United States and 3 other locations
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
La Jolla, California, United States and 56 other locations
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tuspetinib (HM43239) in Patients with Relapsed or Refractory Acute...
Phase 1, Phase 2
La Jolla, California, United States of America and 33 other locations
This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) ...
Phase 3
San Diego, California, United States and 222 other locations
This is a Phase 1/2a, multicenter, open-label, first-in-human (FIH) study of VOR33 in participants with AML or MDS who are undergoing human ...
Phase 1, Phase 2
La Jolla, California, United States and 10 other locations
This study is a Phase 2 multicenter study with a Safety Lead-in evaluating safety and efficacy of MT-401 administration to patients with AML...
Phase 2
La Jolla, California, United States and 17 other locations
T cell therapy (VCAR33) in patients with relapsed or refractory Acute Myeloid Leukemia (AML) after human leukocyt...
Phase 1, Phase 2
La Jolla, California, United States and 11 other locations
This trial evaluates how well CPX-351 and enasidenib work in treating patients with acute myeloid leukemia characterized b...
Phase 2
San Diego, California, United States and 2 other locations
drugs in treating pediatric and young adult patients with acute myeloid leukemia (AML) or acute leukemia...
Phase 1
San Diego, California, United States and 9 other locations
in combination with chemotherapy to treat relapsed/refractory AML, compared to chemotherapy alone. The safety of uproleselan when given with...
Phase 3
La Jolla, California, United States and 69 other locations
Clinical trials
Research sites
Resources
Legal